Synkrino Biotherapeutics


Developer of novel therapeutics designed to treat patients with diseases driven by the immune system and inflammation. The company’s therapeutics use AI Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue of patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.

450 Sutardja Dai Hall UC Berkeley
Berkeley, CA 94709